Science behind phase I clinical trials: targeting tumour cell development pathways
4 Nov 2026
Science behind phase I clinical trials: targeting tumour cell development pathways
ASCO 2013 highlights
Next generation of anti-cancer agents: data from ASCO 2013
Bevacizumab extends survival for relapsed and advanced cervical cancer
Cetuximab superior to bevacizumab for advanced colorectal cancer
Cetuximab superior to bevacizumab for advanced colorectal cancer
Racial disparities in cancer outcomes
Robotic TME with coloanal anastomosis. Technical aspects (Video only)
Robotic gastrectomy for gastric cancer
Personalised medicine in metastatic colorectal cancer
Prognostic signatures in colon cancer
Targeted therapies for colorectal cancer